RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
151 hedge funds and large institutions have $827M invested in Revance Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 158 → 151 (-7)
44% less capital invested
Capital invested by funds: $1.48B → $827M (-$650M)
Holders
151
Holding in Top 10
2
Calls
$11.7M
Puts
$9.78M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$22.3M | |
| 3 | +$19.1M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$12.2M |
| 5 |
D.E. Shaw & Co
New York
|
+$8.4M |
Top Sellers
| 1 | -$78.2M | |
| 2 | -$51.2M | |
| 3 | -$24.7M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$11.3M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$10.6M |